Weaver Consulting Group Sorrento Therapeutics, Inc. Transaction History

Weaver Consulting Group

  • $287 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 09, 2023
BUY
$0.74 - $1.83 $26,270 - $64,965
35,500 Added 351.49%
45,600 $0
Q3 2022

Oct 04, 2022
BUY
$1.51 - $2.88 $15,251 - $29,088
10,100 New
10,100 $16,000
Q4 2020

Jan 29, 2021
SELL
$5.76 - $11.95 $864 - $1,792
-150 Closed
0 $0
Q3 2020

Oct 28, 2020
BUY
$6.17 - $18.82 $925 - $2,823
150 New
150 $2,000

Others Institutions Holding SRNE

# of Institutions
12
Shares Held
5.47M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Weaver Consulting Group Portfolio

Follow Weaver Consulting Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weaver Consulting Group, based on Form 13F filings with the SEC.

News

Stay updated on Weaver Consulting Group with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email